Skip to main content
. 2020 May 29;52:110–115. doi: 10.1016/j.breast.2020.05.006

Table 1.

Primary systemic therapy before and during COVID-19.

Rate of primary systemic therapy Prior COVID-19 During COVID-19 P value
<10% 39 (10.3%) 88 (23.3%) 0.0001
10–20% 159 (42.2%) 143 (37.9%) 0.2645
21–30% 127 (33.7%) 100 (26.5%) 0.0383
>30% 52 (13.8%) 46 (12.2%) 0.5883